Chocolate tested for kidney effects – but Don't get excited yet
NCT ID NCT05755217
First seen Jun 24, 2026 · Last updated Jun 30, 2026 · Updated 4 times
Summary
This study looks at whether eating a single dose of dark chocolate (70% cocoa) changes blood flow to the kidneys and blood pressure, compared to white chocolate. Researchers will use ultrasound to measure kidney blood flow two hours after eating. The study includes 32 people: healthy volunteers and those with mild-to-moderate chronic kidney disease. It's a small, early-stage study that aims to gather basic knowledge, not to prove any treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dark chocolate (70% cocoa) and white chocolate (4% cocoa)
- What this could lead to
- If it works, this could help us understand whether dark chocolate has any short-term benefits for kidney function and blood pressure.
- What could go wrong
- This is a very small, early study (32 people) looking only at immediate effects after a single dose. It won't prove any long-term health benefits or risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
33 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria for healthy volunteers: * Age ≥ 18 years old * ability to understand the study protocol and to sign an informed consent. Inclusion criteria for CKD patients: * Age ≥18 years old, * CKD stage 1-3, * ability to understand the study protocol and to sign an informed consent Exclusion Criteria: * Lactose or cocoa intolerance, * Diabetes, * any severe digestive issue and liver disease, * history of kidney stones, * inability to follow the procedures of the study, e.g. due to language problems, dementia, etc. * pregnant women * healthy volunteers taking antihypertensive medication * healthy volunteers having a known kidney malformation or abnormality * healthy volunteers with albuminuria and/or hematuria in the urine sample. * CKD patients with an eGFR\<30ml/min/1.73m2 * CKD patients with measured kalemia of \> 5.5mmol/l in the last three months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chocolate consumption are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Nephrology, Centre Hospitalier Universitaire Vaudois
Lausanne, Canton of Vaud, 1011, Switzerland
-
University Hospital of Lausanne (CHUV)
Lausanne, Canton of Vaud, 1011, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI food photos and a chatbot take aim at kidney disease diets
- Can a breathing workout and walks help dialysis patients with irregular heartbeats?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Can a Patient's own kidney cells hold off dialysis?
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Two drugs, one goal: can finerenone or semaglutide cut kidney damage markers?